ALLERGAN INC AGN Cash Flow

Allergan inc (AGN)

CashFlow / Yearly

Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09	Dec'08	Dec'07
Cash flows from operating activities:
Net earnings
1,528,800	988,700	1,102,500	938,100	4,900	623,800	564,700	485,300
Non-cash items included in net earnings:
Depreciation and amortization
248,100	254,600	256,600	253,400	257,100	262,100	264,400	215,500
In-process research and development charge
-	-	-	-	-	-	-	72,000
Settlement of a pre-existing distribution agreement in a business combination
-	-	-	-	-	-	-	-2,300
Amortization of original issue discount and debt issuance costs
2,800	2,600	1,900	9,700	28,400	27,500	29,400	28,500
Amortization of net realized gain on interest rate swaps
-15,000	-14,400	-7,700	-1,300	-1,300	-1,300	-1,300	-1,300
Deferred income tax benefit
-79,800	-192,200	-88,300	-68,900	-249,100	-112,800	-101,000	-91,000
Loss on disposal and impairment of assets
-29,800	-5,800	-5,700	0	-17,900	-3,800	11,500	-4,300
Loss on extinguishment of convertible debt
-	-	-	-	-	-5,300	0	0
Unrealized (gain) loss on derivative instruments
37,200	10,400	-15,300	11,100	-7,600	-13,600	-14,800	-400
Expense of share-based compensation plans
159,700	114,400	109,100	86,300	73,900	151,900	93,100	81,700
Loss on sale of discontinued operations
0	-408,200	0	0	-	-	-	-1,300
Legal settlement
-	-	-	-	15,200	0	0	-
Impairment of intangible assets and related costs
0	11,400	22,300	20,400	369,100	0	-	-
(Income) expense from changes in fair value of contingent consideration
-15,100	70,700	5,400	11,900	7,900	0	0	-
Provision for losses on trade receivables in Venezuela
37,300	0	0	-	-	-	-	-
Restructuring charges
246,400	5,500	5,700	4,600	300	50,900	41,300	26,800
Intangible asset impairment
-	-	-	-	-	-	0	-
Loss on investments
-3,100	-3,700	0	-1,300	0	24,600	0	0
Pension and other post-retirement benefit plans settlements and curtailments
12,100	0	0	-	-	-	-	-
Changes in operating assets and liabilities:
Trade receivables
115,700	139,600	34,300	105,600	71,400	17,700	-114,500	46,400
Inventories
43,800	26,900	7,300	24,000	5,600	-67,700	-48,000	22,600
Other current assets
23,300	800	16,000	33,100	-7,300	-4,900	4,600	20,700
Other non-current assets
29,700	15,500	-44,100	13,400	18,600	20,300	-2,900	34,300
Accounts payable
1,900	37,400	32,700	-19,300	8,600	22,500	-32,900	51,800
Accrued expenses
115,900	110,200	73,100	39,100	34,400	16,200	14,000	32,700
Income taxes
-124,000	64,900	52,400	-19,800	-17,600	-1,600	35,300	-18,700
Other liabilities
25,500	17,100	26,700	13,600	-5,100	41,400	-60,400	25,600
Net cash provided by operating activities
1,927,800	1,695,400	1,599,900	1,081,900	463,900	1,113,300	682,500	793,200
Cash flows from investing activities:
Purchases of short-term investments
1,269,800	1,025,600	865,200	571,100	824,100	0	0	-
Purchases of equity investments
20,300	0	0	-	-	-	-	-
Acquisitions, net of cash acquired
67,500	892,100	349,200	101,400	69,800	12,800	150,100	683,700
Additions to property, plant and equipment
243,900	171,900	143,300	118,600	102,800	95,800	190,800	142,500
Additions to capitalized software
19,000	11,800	13,900	11,200	13,300	26,600	56,300	30,700
Additions to intangible assets
15,000	300	4,100	300	40,900	3,300	69,800	10,000
Proceeds from maturities of short-term investments
1,815,900	683,200	784,600	1,140,300	75,000	0	0	-
Proceeds from sale of business
1,800	42,700	0	0	-	-	-	-
Proceeds from sale of equity investments
-	-	-	1,900	0	28,200	0	0
Contractual purchase price adjustment to prior acquisition
-	-	-	-	1,700	-11,600	0	0
Proceeds from sale of business and assets
-	-	-	-	-	-	6,100	23,900
Proceeds from sale of property, plant and equipment
500	500	1,800	1,200	400	0	1,200	9,200
Net cash provided by (used in) investing activities
182,700	-1,375,300	-589,300	340,800	-977,200	-98,700	-459,700	-833,800
Cash flows from financing activities:
Repayments of convertible borrowings
-	-	-	808,900	0	98,300	0	0
Dividends to stockholders
59,600	59,400	60,400	61,100	60,600	60,600	60,700	60,800
Payments to acquire treasury stock
839,200	650,700	909,000	461,700	286,000	105,500	230,100	186,500
Purchase of noncontrolling interest in a subsidiary
0	18,000	0	0	-	-	-	-
Payments of contingent consideration
10,200	61,200	5,100	3,000	0	0	-	-
Net borrowings (repayments) of notes payable
16,500	6,800	-35,100	30,700	6,600	12,100	-34,700	-108,500
Debt issuance costs
0	4,800	0	0	6,100	0	0	-
Proceeds from issuance of senior notes, net of discount
0	598,500	0	0	648,000	0	0	-
Sale of stock to employees
521,000	179,300	246,400	264,000	234,000	63,500	51,600	137,400
Excess tax benefits from share-based compensation
167,500	37,700	45,700	37,700	27,100	7,300	11,100	36,000
Net cash (used in) provided by financing activities
-204,000	28,200	-717,500	-1,002,300	563,000	-181,500	-262,800	-182,400
Effect of exchange rate changes on cash and equivalents
-41,200	-4,000	2,600	-5,500	-5,600	3,600	-7,500	11,500
Net increase in cash and equivalents
1,865,300	344,300	295,700	414,900	44,100	836,700	-47,500	-211,500
Supplemental disclosure of cash flow information
Cash paid for:
Interest, net of amount capitalized
83,400	83,300	64,200	64,500	48,000	53,700	60,700	63,100
Income taxes, net of refunds
487,800	455,300	407,000	399,300	410,800	332,600	261,400	238,000